CPRIT
March Biosciences Nabs $13.4 CPRIT Grant to Advance CAR T-Cell Therapy
The Baylor College of Medicine spinout plans to launch a Phase II trial of its CD5-directed CAR T-cell therapy MB-105 next year.
Baylor Team Aims to Identify Chemo Toxicity Biomarkers in Latino Pediatric Leukemia Patients
Premium
The CPRIT-funded study will examine clinical and genomic data from more than 2,000 Latino patients with acute lymphoblastic leukemia treated with high-dose chemo.
Emtora Nets $16.9M Grant to Advance Drug for Genetic Condition That Increases Colon Cancer Risk
The firm will use the $16.9 million CPRIT grant to launch a registrational trial of encapsulated rapamycin to treat familial adenomatous polyposis.
A recent $4 million grant will help double the size of the database, which is already helping researchers study links between genetic ancestry and cancer treatment outcomes.